Latest filing published 03 Feb 2026 for Atea Pharmaceuticals, Inc., €57k.
Maria Arantxa Horga is a declared insider of Atea Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 31 January 2024 and the latest from 31 January 2026.
On the market, this insider has only sold: 1 sale, €56k in total. Outside the open market, there are 3 share grants and 3 option exercises.
The record was last updated on 3 February 2026 with a share grant (€57k) in Atea Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations